Entera Bio Ltd.

ENTXW CIK: 0001638097

Company Information

Industry Biological Products, (No Diagnostic Substances)
SIC Code 2836
Entity Type operating
SEC Category Non-accelerated filerSmaller reporting company
State of Incorporation Israel
Country Israel
Business Address KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM, , 9112002
Mailing Address KIRYAT HADASSAH, MINRAV BUILDING, JERUSALEM, , 9112002
Phone 972-2-532-7151
Fiscal Year End 1231
EIN 000000000

Financial Overview

FY2025

-$9.54M
Net Income
$2.89M
Total Liabilities

Recent SEC Filings

Form Type Date Filed Document
10-K Annual financial report March 27, 2026 View on SEC
8-K Current report of material events March 27, 2026 View on SEC
4 Insider stock transaction report March 11, 2026 View on SEC
4 Insider stock transaction report March 9, 2026 View on SEC
8-K Current report of material events March 4, 2026 View on SEC
4 Insider stock transaction report February 17, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC
4 Insider stock transaction report February 11, 2026 View on SEC

Annual Reports

10-K March 27, 2026
  • Proprietary N-Tab® technology enables oral delivery of proteins and peptides, replacing painful daily injections.
  • Lead drug candidate EB613 successfully increased bone density in early trials and is advancing toward Phase 3.
View Analysis

Insider Trading

BUY 5 insiders 8 recent transactions
View Full Insider Trading Profile

Related Companies

Companies in the same industry (SIC: 2836)

Investor Resources

Learn more about SEC filings and how to research public companies.

Important Disclaimer

This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.